• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Carlisle Companies Announces Leadership Appointments

    5/16/25 4:05:00 PM ET
    $CAH
    $CSL
    $SUM
    $WU
    Other Pharmaceuticals
    Health Care
    Specialty Chemicals
    Industrials
    Get the next $CAH alert in real time by email

    Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer.

    Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensuring compliance with corporate governance requirements. Prior to Summit Materials, Mr. Gaskill served as Senior Director and Counsel at The Western Union Company (NYSE:WU), Senior Counsel at Cardinal Health Inc. (NYSE:CAH) and an attorney at Simpson, Thacher & Bartlett LLP. Mr. Gaskill holds a Juris Doctor degree from the University of Virginia School of Law.

    Mr. Selbach served as Executive Vice President, Secretary & General Counsel of the Company since January 2023 and Vice President, Secretary & General Counsel from May 2018. Over his more than 30 years of employment with Carlisle, Mr. Selbach has also served as Vice President, Corporate Development and Vice President, Europe.

    Mr. Koch stated, "I am extremely pleased to announce these leadership appointments. Chris is an experienced leader with a broad range of legal and functional expertise and is a proactive, strategic business partner with a strong track record of providing insightful counsel. Scott is a multi-disciplined executive with deep roots in Carlisle who in his new role will work with legislative bodies and government agencies to promote Carlisle's innovative energy-efficient products. These appointments are further examples of how Carlisle continues to invest in exceptional talent in support of our Vision 2030 objectives."

    About Carlisle Companies Incorporated

    Carlisle Companies Incorporated is a leading supplier of innovative building envelope products and solutions for more energy efficient buildings. Through its building products businesses – Carlisle Construction Materials ("CCM") and Carlisle Weatherproofing Technologies ("CWT") – and family of leading brands, Carlisle delivers innovative, labor reducing and environmentally responsible products and solutions to customers through the Carlisle Experience. Carlisle is committed to generating superior shareholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Leveraging its culture of continuous improvement as embodied in the Carlisle Operating System ("COS"), Carlisle has committed to achieving net-zero greenhouse gas emissions by 2050.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250515593954/en/

    Mehul Patel

    Vice President, Investor Relations

    Carlisle Companies Incorporated

    (310) 592 - 9668

    [email protected]

    Get the next $CAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAH
    $CSL
    $SUM
    $WU

    CompanyDatePrice TargetRatingAnalyst
    Cardinal Health Inc.
    $CAH
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    Western Union Company
    $WU
    6/2/2025Perform
    Oppenheimer
    Western Union Company
    $WU
    4/24/2025$7.50Neutral → Sell
    Monness Crespi & Hardt
    Cardinal Health Inc.
    $CAH
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    Cardinal Health Inc.
    $CAH
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    Cardinal Health Inc.
    $CAH
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    Cardinal Health Inc.
    $CAH
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    Summit Materials Inc.
    $SUM
    12/16/2024$58.00 → $52.50Buy → Hold
    Jefferies
    More analyst ratings

    $CAH
    $CSL
    $SUM
    $WU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Legal Officer Adams Benjamin Carlton covered exercise/tax liability with 13,866 shares, decreasing direct ownership by 9% to 133,475 units (SEC Form 4)

      4 - Western Union CO (0001365135) (Issuer)

      6/2/25 5:39:38 PM ET
      $WU
      Business Services
      Consumer Discretionary
    • SEC Form 4 filed by Director Collins Jonathan R.

      4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

      6/2/25 5:34:19 PM ET
      $CSL
      Specialty Chemicals
      Industrials
    • SEC Form 4 filed by Director Frias James D

      4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

      6/2/25 5:28:38 PM ET
      $CSL
      Specialty Chemicals
      Industrials

    $CAH
    $CSL
    $SUM
    $WU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • NYSE Content Advisory: Pre-Market update + Voyager, Ategrity pop double digits in debuts

      NEW YORK, June 12, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on June 12th Stocks are down fractionally this morning after the S&P 500 ended a three-day win streak yesterday. The major index is about 2% from its record.Amid the market momentum, Voyager Technologies (NYSE:VOYG) and Ategrity (NYSE: ASIC) popped double digits in their debuts yesterday. Voyager is a $3.1 billion space and defense company. Ategrity is an insurer valued at about $1.2 billio

      6/12/25 8:55:00 AM ET
      $CAH
      $ICE
      Other Pharmaceuticals
      Health Care
      Investment Bankers/Brokers/Service
      Finance
    • Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day

      Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.201Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4Raising long-term target for Other profit to ~10% normalized growth3,4,5Updating GMPD long-term target to $50M+ of profit growth per year after FY26Expecting at least $10B in total adjusted free cash flow over next three yearsRaising baseline share repurchase plans to at least $750M per yearCompany reiterating strateg

      6/12/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $CSL
    $SUM
    $WU
    Leadership Updates

    Live Leadership Updates

    See more
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Carlisle Companies Announces Leadership Appointments

      Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

      5/16/25 4:05:00 PM ET
      $CAH
      $CSL
      $SUM
      $WU
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Industrials
    • Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

      DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

      3/10/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care